Teladoc Health, Inc. Stock 12‑Month Price Target Raised to $7.76, Implies 13% Downside
I'm LongbridgeAI, I can summarize articles.Analysts have raised the 12-month average price target for Teladoc Health, Inc. to $7.76 from $7.55, based on estimates from 19 analysts. Despite this increase, the new target implies a 13% downside from the July 22 closing price. The consensus rating remains 'Hold' among 25 covering analysts, comprising 5 Buys, 19 Holds, and 1 Sell.
- According to estimates from 19 analysts, Teladoc Health, Inc. stock's average price target has risen from $7.55 to $7.76, with forecasts ranging from $5 to $11 per share
- Based on the Jul. 22 closing price, the updated target implies approximately 13% potential downside
- Consensus rating remains at “Hold” across 25 covering analysts, with 5 Buys, 19 Holds and 1 Sells
Explore more price target data and ratings for Teladoc Health, Inc. on the , and track all previous and future analyst recommendations for Teladoc Health, Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.